COGNEX CORP (CGNX) Stock Fundamental Analysis

NASDAQ:CGNX • US1924221039

56.03 USD
+0.09 (+0.16%)
At close: Feb 20, 2026
55.51 USD
-0.52 (-0.93%)
After Hours: 2/20/2026, 8:22:43 PM
Fundamental Rating

6

CGNX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 122 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, CGNX is valued expensive at the moment. With these ratings, CGNX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CGNX had positive earnings in the past year.
  • CGNX had a positive operating cash flow in the past year.
  • CGNX had positive earnings in each of the past 5 years.
  • CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CGNX's Return On Assets of 5.68% is fine compared to the rest of the industry. CGNX outperforms 75.41% of its industry peers.
  • CGNX has a better Return On Equity (7.67%) than 63.93% of its industry peers.
  • The Return On Invested Capital of CGNX (6.36%) is better than 64.75% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CGNX is below the industry average of 8.80%.
  • The last Return On Invested Capital (6.36%) for CGNX is above the 3 year average (5.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.68%
ROE 7.67%
ROIC 6.36%
ROA(3y)5.54%
ROA(5y)8.32%
ROE(3y)7.4%
ROE(5y)11.35%
ROIC(3y)5.2%
ROIC(5y)7.78%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CGNX has a Profit Margin of 11.51%. This is amongst the best in the industry. CGNX outperforms 88.52% of its industry peers.
  • CGNX's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CGNX (16.35%) is better than 90.98% of its industry peers.
  • CGNX's Operating Margin has declined in the last couple of years.
  • CGNX has a Gross Margin of 66.92%. This is amongst the best in the industry. CGNX outperforms 97.54% of its industry peers.
  • In the last couple of years the Gross Margin of CGNX has declined.
Industry RankSector Rank
OM 16.35%
PM (TTM) 11.51%
GM 66.92%
OM growth 3Y-15.08%
OM growth 5Y-8.44%
PM growth 3Y-18.7%
PM growth 5Y-11.93%
GM growth 3Y-2.3%
GM growth 5Y-2.14%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGNX is destroying value.
  • Compared to 1 year ago, CGNX has less shares outstanding
  • The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
  • There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 12.07 indicates that CGNX is not in any danger for bankruptcy at the moment.
  • CGNX has a Altman-Z score of 12.07. This is amongst the best in the industry. CGNX outperforms 89.34% of its industry peers.
  • CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.07
ROIC/WACC0.67
WACC9.48%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • CGNX has a Current Ratio of 3.80. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.80, CGNX is doing good in the industry, outperforming 73.77% of the companies in the same industry.
  • A Quick Ratio of 3.05 indicates that CGNX has no problem at all paying its short term obligations.
  • CGNX's Quick ratio of 3.05 is fine compared to the rest of the industry. CGNX outperforms 74.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 3.05
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

  • CGNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.49%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -0.77% on average over the past years.
  • Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 8.73% in the last year.
  • The Revenue has been growing slightly by 4.16% on average over the past years.
EPS 1Y (TTM)36.49%
EPS 3Y-8.3%
EPS 5Y-0.77%
EPS Q2Q%35%
Revenue 1Y (TTM)8.73%
Revenue growth 3Y-0.39%
Revenue growth 5Y4.16%
Sales Q2Q%9.86%

3.2 Future

  • Based on estimates for the next years, CGNX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.09% on average per year.
  • CGNX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.76% yearly.
EPS Next Y14.43%
EPS Next 2Y17.74%
EPS Next 3Y28.48%
EPS Next 5Y22.09%
Revenue Next Year8.39%
Revenue Next 2Y9.03%
Revenue Next 3Y9.55%
Revenue Next 5Y1.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 55.48 indicates a quite expensive valuation of CGNX.
  • The rest of the industry has a similar Price/Earnings ratio as CGNX.
  • CGNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.99.
  • The Price/Forward Earnings ratio is 48.48, which means the current valuation is very expensive for CGNX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CGNX is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. CGNX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 55.48
Fwd PE 48.48
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CGNX is on the same level as its industry peers.
  • CGNX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGNX is cheaper than 64.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.66
EV/EBITDA 46.36
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CGNX has a very decent profitability rating, which may justify a higher PE ratio.
  • CGNX's earnings are expected to grow with 28.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.85
PEG (5Y)N/A
EPS Next 2Y17.74%
EPS Next 3Y28.48%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.61%, CGNX is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.49, CGNX pays a better dividend. On top of this CGNX pays more dividend than 82.79% of the companies listed in the same industry.
  • With a Dividend Yield of 0.61, CGNX pays less dividend than the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

  • The dividend of CGNX decreases each year by -32.10%.
  • CGNX has paid a dividend for at least 10 years, which is a reliable track record.
  • CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.1%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 47.73% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
DP47.73%
EPS Next 2Y17.74%
EPS Next 3Y28.48%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (2/20/2026, 8:22:43 PM)

After market: 55.51 -0.52 (-0.93%)

56.03

+0.09 (+0.16%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)04-28
Inst Owners104.09%
Inst Owner Change7.75%
Ins Owners0.27%
Ins Owner Change-0.15%
Market Cap9.39B
Revenue(TTM)994.36M
Net Income(TTM)114.44M
Analysts76.55
Price Target48.46 (-13.51%)
Short Float %4.11%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.32
Dividend Growth(5Y)-32.1%
DP47.73%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-26
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.94%
Min EPS beat(2)11.87%
Max EPS beat(2)20%
EPS beat(4)4
Avg EPS beat(4)13.62%
Min EPS beat(4)3.71%
Max EPS beat(4)20%
EPS beat(8)8
Avg EPS beat(8)17.01%
EPS beat(12)12
Avg EPS beat(12)18.03%
EPS beat(16)14
Avg EPS beat(16)15.8%
Revenue beat(2)2
Avg Revenue beat(2)3.4%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.51%
Revenue beat(4)2
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)0.87%
Revenue beat(12)7
Avg Revenue beat(12)1.04%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)-0.63%
PT rev (3m)-0.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.84%
EPS NY rev (1m)0%
EPS NY rev (3m)1.13%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 55.48
Fwd PE 48.48
P/S 9.44
P/FCF 39.66
P/OCF 38.25
P/B 6.29
P/tB 9.17
EV/EBITDA 46.36
EPS(TTM)1.01
EY1.8%
EPS(NY)1.16
Fwd EY2.06%
FCF(TTM)1.41
FCFY2.52%
OCF(TTM)1.46
OCFY2.61%
SpS5.93
BVpS8.9
TBVpS6.11
PEG (NY)3.85
PEG (5Y)N/A
Graham Number14.22
Profitability
Industry RankSector Rank
ROA 5.68%
ROE 7.67%
ROCE 8.87%
ROIC 6.36%
ROICexc 7.79%
ROICexgc 11.33%
OM 16.35%
PM (TTM) 11.51%
GM 66.92%
FCFM 23.81%
ROA(3y)5.54%
ROA(5y)8.32%
ROE(3y)7.4%
ROE(5y)11.35%
ROIC(3y)5.2%
ROIC(5y)7.78%
ROICexc(3y)6.25%
ROICexc(5y)9.59%
ROICexgc(3y)9.12%
ROICexgc(5y)12.58%
ROCE(3y)7.25%
ROCE(5y)10.86%
ROICexgc growth 3Y-13.1%
ROICexgc growth 5Y-4.48%
ROICexc growth 3Y-17.85%
ROICexc growth 5Y-7.32%
OM growth 3Y-15.08%
OM growth 5Y-8.44%
PM growth 3Y-18.7%
PM growth 5Y-11.93%
GM growth 3Y-2.3%
GM growth 5Y-2.14%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 28.39%
Cap/Sales 0.88%
Interest Coverage 250
Cash Conversion 126.97%
Profit Quality 206.89%
Current Ratio 3.8
Quick Ratio 3.05
Altman-Z 12.07
F-Score8
WACC9.48%
ROIC/WACC0.67
Cap/Depr(3y)59.96%
Cap/Depr(5y)71.35%
Cap/Sales(3y)1.76%
Cap/Sales(5y)1.75%
Profit Quality(3y)137.49%
Profit Quality(5y)124.59%
High Growth Momentum
Growth
EPS 1Y (TTM)36.49%
EPS 3Y-8.3%
EPS 5Y-0.77%
EPS Q2Q%35%
EPS Next Y14.43%
EPS Next 2Y17.74%
EPS Next 3Y28.48%
EPS Next 5Y22.09%
Revenue 1Y (TTM)8.73%
Revenue growth 3Y-0.39%
Revenue growth 5Y4.16%
Sales Q2Q%9.86%
Revenue Next Year8.39%
Revenue Next 2Y9.03%
Revenue Next 3Y9.55%
Revenue Next 5Y1.76%
EBIT growth 1Y41.28%
EBIT growth 3Y-15.41%
EBIT growth 5Y-4.63%
EBIT Next Year32.65%
EBIT Next 3Y27.07%
EBIT Next 5Y21.26%
FCF growth 1Y76.64%
FCF growth 3Y1.91%
FCF growth 5Y0.66%
OCF growth 1Y64.69%
OCF growth 3Y0.29%
OCF growth 5Y0.26%

COGNEX CORP / CGNX FAQ

What is the fundamental rating for CGNX stock?

ChartMill assigns a fundamental rating of 6 / 10 to CGNX.


What is the valuation status for CGNX stock?

ChartMill assigns a valuation rating of 3 / 10 to COGNEX CORP (CGNX). This can be considered as Overvalued.


What is the profitability of CGNX stock?

COGNEX CORP (CGNX) has a profitability rating of 7 / 10.


What is the financial health of COGNEX CORP (CGNX) stock?

The financial health rating of COGNEX CORP (CGNX) is 9 / 10.


How sustainable is the dividend of COGNEX CORP (CGNX) stock?

The dividend rating of COGNEX CORP (CGNX) is 4 / 10 and the dividend payout ratio is 47.73%.